Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Lipman

Showing results (111-120 of 182) with videos related to

Pageof 19
Sort By:
Wellcome Open Research|April 10, 2023
Health economic analyses of latent tuberculosis infection screening and preventive treatment among people living with HIV in lower tuberculosis incidence settings: a systematic reviewRebecca F Baggaley, Carolin Vegvari, Christian A Dimala, et al.
The Lancet. HIV|October 2, 2015
Does antiretroviral therapy reduce HIV-associated tuberculosis incidence to background rates? A national observational cohort study from England, Wales, and Northern IrelandRishi K Gupta, Brian Rice, Alison E Brown, et al.
The Journal of Antimicrobial Chemotherapy|August 14, 2020
Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosisArundhati Maitra, Dimitrios Evangelopoulos, Alina Chrzastek, et al.
Thorax|March 26, 2015
Impact of TB on the survival of people living with HIV infection in England, Wales and Northern IrelandDominik Zenner, Ibrahim Abubakar, Stefano Conti, et al.
Journal of Public Health (Oxford, England)|May 18, 2025
A decision-making model for public health authorities in circumstances of potentially high public riskFatima N Dalal, Simon E Kolstoe, Yimmy Y Chow, et al.
AIDS (London, England)|November 22, 2023
Screening for tuberculosis infection and effectiveness of preventive treatment among people with HIV in low-incidence settingsDorine van Geuns, Rob J W Arts, Gerard de Vries, et al.
The Journal of Antimicrobial Chemotherapy|June 7, 2011
Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practiceAnn Sturdy, Anna Goodman, Ricardo J José, et al.
Frontiers in Immunology|March 18, 2021
Persistent T Cell Repertoire Perturbation and T Cell Activation in HIV After Long Term TreatmentCarolin T Turner, James Brown, Emily Shaw, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2013
Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trialsPunam Mangtani, Ibrahim Abubakar, Cono Ariti, et al.
Health Technology Assessment (Winchester, England)|May 9, 2015
Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosisFrancis Drobniewski, Mary Cooke, Jake Jordan, et al.
Pageof 19

Showing results (111-120 of 182) with videos related to

Sort By:
Pageof 19
Wellcome Open Research|April 10, 2023
Health economic analyses of latent tuberculosis infection screening and preventive treatment among people living with HIV in lower tuberculosis incidence settings: a systematic reviewRebecca F Baggaley, Carolin Vegvari, Christian A Dimala, et al.
The Lancet. HIV|October 2, 2015
Does antiretroviral therapy reduce HIV-associated tuberculosis incidence to background rates? A national observational cohort study from England, Wales, and Northern IrelandRishi K Gupta, Brian Rice, Alison E Brown, et al.
The Journal of Antimicrobial Chemotherapy|August 14, 2020
Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosisArundhati Maitra, Dimitrios Evangelopoulos, Alina Chrzastek, et al.
Thorax|March 26, 2015
Impact of TB on the survival of people living with HIV infection in England, Wales and Northern IrelandDominik Zenner, Ibrahim Abubakar, Stefano Conti, et al.
Journal of Public Health (Oxford, England)|May 18, 2025
A decision-making model for public health authorities in circumstances of potentially high public riskFatima N Dalal, Simon E Kolstoe, Yimmy Y Chow, et al.
AIDS (London, England)|November 22, 2023
Screening for tuberculosis infection and effectiveness of preventive treatment among people with HIV in low-incidence settingsDorine van Geuns, Rob J W Arts, Gerard de Vries, et al.
The Journal of Antimicrobial Chemotherapy|June 7, 2011
Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practiceAnn Sturdy, Anna Goodman, Ricardo J José, et al.
Frontiers in Immunology|March 18, 2021
Persistent T Cell Repertoire Perturbation and T Cell Activation in HIV After Long Term TreatmentCarolin T Turner, James Brown, Emily Shaw, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2013
Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trialsPunam Mangtani, Ibrahim Abubakar, Cono Ariti, et al.
Health Technology Assessment (Winchester, England)|May 9, 2015
Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosisFrancis Drobniewski, Mary Cooke, Jake Jordan, et al.
Pageof 19